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Abstract
The aim of this prospective study was to investigate changes in muscle activity during gait
in children with Duchennemuscular Dystrophy (DMD). Dynamic surface electromyography
recordings (EMGs) of 16 children with DMD and pathological gait were compared with
those of 15 control children. The activity of the rectus femoris (RF), vastus lateralis (VL),
medial hamstrings (HS), tibialis anterior (TA) and gastrocnemius soleus (GAS) muscles
was recorded and analysed quantitatively and qualitatively. The overall muscle activity in
the children with DMDwas significantly different from that of the control group. Percentage
activation amplitudes of RF, HS and TA were greater throughout the gait cycle in the chil-
dren with DMD and the timing of GAS activity differed from the control children. Significantly
greater muscle coactivation was found in the children with DMD. There were no significant
differences between sides. Since the motor command is normal in DMD, the hyper-activity
and co-contractions likely compensate for gait instability and muscle weakness, however
may have negative consequences on the muscles andmay increase the energy cost of
gait. Simple rehabilitative strategies such as targeted physical therapiesmay improve sta-
bility and thus the pattern of muscle activity.
Introduction
DuchenneMuscular Dystrophy (DMD) is the most common neuromuscular disease in chil-
dren, with an incidence of 1 in 3500 male births [1]. It causes a lack of dystrophin in the mus-
cles, leading to a progressive degeneration of muscle fibres and generalisedmuscle weakness
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[2]. Gait begins to deteriorate between the ages of 3 and 6 years [3] and is lost at around 10–12
years of age [4]. Gait loss is a milestone in the progression of the disease.
Case-control studies using optoelectronic systems to analyse gait have shown kinematic
anomalies at the pelvis (lumbar hyperlordosis, excessive anterior pelvic tilt, double bump pat-
tern), the knee (loss of knee flexion in stance and excessive extension at the end of stance) and
the ankle (increased plantarflexion in swing, toe-walking) [3,5–14]. These pathological patterns
are the result of a slow, poorly-understoodprocess caused by a combination of muscle weak-
ness, muscle shortening and osteo-articular changes, along with postural adaptations.
The underlying patterns of muscle activity have, however, been little studied. There is thus a
lack of understanding of the specific role of each lower limb muscle in the abnormal gait pat-
terns. In 1981, Sutherland et al. [5] found abnormal activation of the hamstrings (HS), tibialis
anterior (TA) and gastrocnemius-soleus (GAS) muscles. More recently, Patte et al. found
excessive and/or prolonged activity of the gluteus maximus, rectus femoris (RF), HS and TA
while the activity of other muscles, such as GAS, was close to normal [11]. However, the
description of electromyographical (EMG) activity in the literature is generally limited because
it was not the primary aim of these studies, and most used qualitative methods. In DMD, the
efferent motor command is considered to be intact, thus changes in muscle activity during gait
are the direct result of the disease on the muscles. Analysis of muscle activation during the gait
cycle as well as intra-segment agonist/antagonist coactivation would be useful to identify
“dynamic” muscle adaptations to compensate for weakness and stabilise gait. Knowledge of
these adaptations would help to guide gait rehabilitation as well as all types of medical and sur-
gical interventions (splinting, surgery, intra-muscular treatments etc.). It would also help to
determine whether alternative rehabilitative strategies decrease compensatory muscle activity.
The primary aim of this study was to compare muscle activation and coactivation in the
lower limbs during the gait cycle in children with DMD with typically developing children of
the same age. We hypothesised that abnormal patterns of muscle activity would be found in
the different segments of the lower limbs in the children with DMD. The secondary aim was to
explore the relationship betweenmuscle activation, lower limb kinematics and functional
status.
Research Design andMethods
Ethics statement
This observational case/control study was approved by the ethics committee “Comité de Pro-
tection des Personnes Ouest VI”. The children and parents were given an information letter
and signed a consent form for participation in the study, according to French legislation.
Participants
Children with DMD were recruited in 5 centers specialised in DMD in France who all had
optoelectronic gait recording systems (Centre de l’Arche du Mans, CHRU de Brest, CHRU de
Lille, CHRU de Nantes, CHRU de Lyon). The criteria for inclusion in the study were: (1)
DuchenneMuscular Dystrophy confirmed by dystrophin marking in immunohistochemistry,
frommuscle biopsy and/or mutation of the dystrophin gene found in molecular biology, (2)
boys<18 years of age, (3) able to walk 10 metres without using aids, (4) pathological gait pat-
tern (marked hyperlordosis, toe-walking, shoulder tilt found during a routine medical consul-
tation. In order to confirm this last criterion, the children underwent gait analysis and were
included if they had a Gait Profile Score (GPS) which deviated by more than 1.6° (on the left or
right) from the mean of the group of healthy subjects. This deviation threshold, calculated by
Baker et al. [15] as the Minimum Clinically Important Difference for the GPS, provided a
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criterion from which ‘pathological gait’ could be objectively determined. Children who had
undergone orthopaedic surgery of the lower limbs within the previous 6 months were excluded,
as were children with cognitive deficits or behavioural difficultieswhich would have limited
comprehension and participation in the study. Twenty children underwent gait analysis and 16
were included in the final analysis based on their GPS. Fifteen control boys aged from 6 to 13
years with no gait anomalies were also included. The group of children with DMD and the con-
trol children were all male and were similar in terms of age and BodyMass Index (Table 1), fac-
tors which can influence gait parameters [16].
Data collection
The following data were recorded during the clinical examination: medication (particularly
corticosteroids), scoliosis, anthropometric parameters (height and weight), Vignos functional
rating scale, which classifies children with dystrophinopathies into 10 categories according to
their gait capacity [17], hip, knee and ankle flexor and extensor muscle strength using the Med-
ical Research Council scale (MRC scale) from 0 to 5 [18], and passive range of dorsiflexion
with the knee flexed to evaluate shortening of the triceps surae (Table 2). All the children had
full passive range of motion of the hip or knee (i.e. no contractures).
Table 1. Subject characteristics.
DMD Control p value *
Number of children 16 15
Age (years) (mean and SD) 8.67 (2.04) 9.39 (2.21) 0.42
BMI (kg/m2) (mean ans SD) 16.65 (3.37) 16.07 (1.38) 0.92
Corticotherapy (yes/no) 12 / 4 0
Vignos Lower Extremity scale (max = 10) (mean and SD) 3.37 (1.36)
BMI, body mass index.
* p values were calculated using the MannWhitney test.
doi:10.1371/journal.pone.0161938.t001
Table 2. Values of selectedvariables.
DMD Control p value a
GDI 75.0 (9.84) 100.24 (6.87) ***
GPS 9.32 (2.24) 4.58 (0.74) ***
Gait speed (m/sec) 0.78 (0.18) 1.21 (0.13) ***
Cadence (step/min) 116.26 (16.8) 129.68 (8.41) **
Stride length (m) 0.81 (0.14) 1.13 (0.12) ***
Passive ankle dorsiflexion (degree) 10.94 (10.68)
MRCScale Hip Flexion (N = 16) 3.27 (0.81)
MRCScale Hip Extension (N = 16) 2.88 (0.96)
MRCScale Knee Flexion (N = 16) 3.67 (0.86)
MRCScale Knee Extension (N = 16) 4.00 (0.79)
MRCScale Ankle dorsi flexors (N = 14) 4.23 (0.98)
MRCScale Ankle plantar flexors (N = 14) 4.68 (0.64)
GDI, gait deviation index; GPS, gait profile score; MRCScale, medical research council scale.
a p values were calculated using the MannWhitney test (* p<0.05; ** p<0.01, *** p<0.001).
doi:10.1371/journal.pone.0161938.t002
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The 5 movement laboratories used the same standardized acquisition protocol to collect
spatio-temporal gait parameters (speed, stride length and cadence) and 3D kinematics of the
lower limbs using an optoelectronic system (Vicon MX 13, Oxford metrics, Oxford, UK for 4
laboratories, Motion Analysis, Santa Rosa, CA, USA for 1 laboratory). Sixteen reflectivemark-
ers were positioned on anatomical reference points according to the protocol by Davis et al.
[19]. Muscle activity was recorded using a 16-channel EMG system at a sampling frequency of
1080 Hz (CHRU Brest) or 1000 Hz for the 4 others centres. Pre-amplified surface electrodes
were positioned on the rectus femoris (RF), vastus lateralis (VL), medial hamstrings (HS),
tibialis anterior (TA) and gastrocnemius-soleus (GAS) according to the SENIAM recommen-
dations [20]. The children walked barefoot, without assistance along a 10 metre long walkway.
Five trials were recorded with no instructions regarding gait except to walk at their own com-
fortable pace.
Data processing
In order to standardize the analysis, the same researcher carried out all the data processing and
analysis for all the children (DMD and control) following receipt of the raw data from the 5
laboratories. As well as spatio-temporal and kinematic parameters, two 3D kinematic indexes
were calculated: the Gait Deviation Index (GDI) [21] and Gait Profile Score (GPS) [22]
(Table 2). These validated indexes are classically used to evaluate the quality of gait in children.
The GDI provides a global index of gait quality and the GPS yields a score for each joint and
plane of motion. The GDI is calculated by principal component analysis using all the kinematic
data from the lower limbs and is expressed as a score out of 100. Each decrease of 10 points cor-
responds to a difference of one standard deviation from the control population. The GPS is
obtained from the mean of the differences calculated by the RootMean Square Error (RMSE)
of each joint in each motion plane for a given child compared with the control group. It is
expressed in degrees relative to the “normal” GPS.
The raw EMG signal of each muscle was processed as follows: it was centred by subtracting
the mean of the signal, then rectified by taking the absolute value and filtered (4th order zero
lag Butterworth filter, cut-off frequency: 8.9Hz) [23] to obtain a “linear” envelope of the EMG
signal. In order to compare the profiles of muscle activity, the linear envelops were normalised
by the amplitude of the maximum value of the muscle activity across all the gait cycles of the
child (from 0 to 1 on the y-axis) and expressed as a percentage of the gait cycle (temporal nor-
malisation) (0%: beginning of the cycle with initial contact, to 100%: end of cycle on the x-
axis). For each muscle of each subject, the EMG profile was defined as the mean of the linear
envelope curves of the recorded cycles. Mean linear envelopes and standard deviations were
then calculated for both groups (DMD and control).
The KeR-EGI index, recently developed and validated by Bervet et al. [24], was calculated
for each child (DMD and control). The calculation follows the same methodology as the GDI.
It is based on the Euclidian distance between the EMG pattern of a child with DMD and that of
a group of healthy subjects (principal component analysis), out of 100. A score equal to or
above 100 indicates normal gait and a decrease of 10 points indicates a deviation of 1 standard
deviation from the norm. The KeR-EGI is an index of globalmuscle activity based on the EMG
of all the muscles recorded and does not provide information for individual muscles. In order
to quantify the deviation from the norm of each muscle group independently and for each sub-
ject, the distance from the norm based on the RMSE was calculated, similarly to the calculation
for the GPS. A score without units was obtained for each muscle, which we termed EMG-PS
(EMG-Profile Score). It was calculated for the whole of the gait cycle (EMG-PS) as well as for
stance phase (EMG-PS StP) and swing phase (EMG-PS SwP). Since the stance and swing
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phases were different for each child, they were normalized.We termed the mean of these scores
for each muscle Global EMG-PS.
Coactivation indices (CI) relating to the timing of simultaneous activation of 2 intra- or
inter- segment muscles were calculated following the method described by Unnithan et al. [25]
for 3 agonist-antagonist muscle pairs (RF/HS, VL/HS, GAS/TA) for both lower limbs. This
coactivation index is obtained by calculating the surface of overlap of the envelopes of the mus-
cle pairs, divided by the number of points in the curve (Fig 1).
To summarize, for each child the Ker-EGI, the Global EMG-PS (global index of muscle
activity), the EMG-PS (index of muscle activity for each muscle for the whole of gait cycle,
stance phase and swing phase) and coactivation indexes were calculated for agonist-antagonist
pairs for both lower limbs. The analyses were carried out on the means of the variables for both
groups (control and DMD).
Statistical analysis
BiostaTGV (version 2014) software was used for all the statistical analyses. A Mann Whitney
test was used to compare the variables of the control children and the children with DMD. The
means of the variables of each lower limb of the children with DMD were compared with the
corresponding limbs of the control children.
AWilcoxon signed rank test for paired data was used to compare variables from the left and
right limbs for each child. Since no significant differences were found between the muscle acti-
vations of each limb in either group, the results were pooled across sides for clarity and are pre-
sented by muscle group. A qualitative comparison of the mean activation curveswas carried
out in both groups to compare activation times and the profiles of the curves.
In the DMD group, Spearman’s rank correlation was used to test the association between
muscle activation (Ker-EGI, global EMG-PS), kinematics (GDI, GPS, walking speed) and func-
tional status (Vignos functional score). The threshold for significancewas set to p< 0.05.
Results
Muscle activation profile
The KeR-EGI of the children with DMD was more than 2 standard deviations lower than that
of the control children (76.88 ±16.9 vs 100.10 ±7.90, p<0.001) and the mean EMG-PS of the
Fig 1. Illustration of co-activation index (CI) calculation. The percentageof the gait cycle is presented on
the X-axis (0: heel strike, 100: the following ipsilateral heel strike) and the normalizedamplitude of EMG
activity on the Y-axis (0–1). Lines represent the mean linear envelope of muscle 1 activation. Dashed lines
represent the mean linear envelope of muscle 2 activation. Black color represent muscle activation in the
control group. Blue color representmuscle activation in one child with DMD. The calculation index involved
overlapping the linear envelopes of muscle 1 andmuscle 2, calculating the area of overlap and dividing by the
number of data points. Areas of coactivation are represented in grey (control group) and in blue (DMD
patient).
doi:10.1371/journal.pone.0161938.g001
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children with DMD was significantly higher than that of the control children (0.17 ±0.04 vs
0.13 ±0.03, p<0.001) (Table 3).
Mean EMG-PS and EMG-PS by phase were significantly higher in the children with DMD
for the RF, HS, GAS and TA muscles. There was no difference between groups for the VL.
Activity of the TA (EMG-PS +0.05, p<0.001) and GAS (EMG-PS +0.06, p<0.001) was the
most pathological in stance, and activity of the TA was the most pathological in swing
(EMG-PS +0.09, p<0.001).
Qualitative analysis of the mean muscle activity (fig 2) showed that the percentage activa-
tion of the RF and HS was higher in the children with DMD for almost the whole of the gait
cycle compared with the control children. The percentage activity of the TA was lower between
0–10% and 90–100% of the gait cycle and it was higher during the rest of the gait cycle, particu-
larly during swing. The activity of the GAS was prolonged during stance (up to 60% of the gait
cycle). Its activity was higher between 0 and 20% of the gait cycle (at the beginning of stance).
Coactivation (table 4)
Proximally, there was significantlymore coactivation betweenRF and HS during the whole of
the gait cycle in the children with DMD (+0.06, p<0.05) but there was no significant difference
between groups for the VL/HS pair. Distally, there was significantlymore coactivation between
TA and GAS in the children with DMD (+0.04, p<0.01), particularly during stance.
Correlationsbetweenmuscle activation, kinematics and functional
status (table 5)
The Vignos functional scale was significantly correlated with EMG-PS global in the children
with DMD. Abnormal kinematic gait patterns (evaluated by the GDI and GPS) were also sig-
nificantly correlated with global indexes of muscle activity (Ker-EGI and EMG-PS global).
Proximally, the RF/HS coactivation index was significantly associated with a high Vignos score
and pathological kinematic gait pattern (GDI, GPS). Distally, there were significantly correla-
tions between the TA/GAS coactivation index and kinematic indexes. Walking speed was not
statistically associated with muscle activity, except for the VL/HS coactivation index.
Table 3. Global index ofmuscle activity (Ker-EGI and global EMG-PS) and index ofmuscle activity for eachmuscle for thewhole gait cycle, stance
phase and swing phase (EMG-PS).
Gait cycle Stance phase Swing phase
DMD Control p DMD Control p DMD Control p
KeR-EGI 76.88 (16.9) 100.10 (7.90) ***
EMG-PS global 0.17 (0.04) 0.13 (0.03) *** 0.18 (0.04) 0.13 (0.01) *** 0.15 (0.04) 0.10 (0.02) ***
EMG-PSRectus Femoris 0.17 (0.06) 0.13 (0.02) * 0.16 (0.06) 0.11 (0.03) * 0.18 (0.06) 0.12 (0.03) *
EMG-PSVastus Lateralis 0.14 (0.03) 0.13 (0.03) p = 0.13 0.15 (0.05) 0.12 (0.02) p = 0.09 0.11 (0.03) 0.10 (0.02) p = 0.28
EMG-PSHamstring 0.18 (0.04) 0.15 (0.03) ** 0.18 (0.06) 0.15 (0.03) * 0.16 (0.05) 0.11 (0.02) **
EMG-PSTibialis anterior 0.20 (0.03) 0.14 (0.04) *** 0.18 (0.03) 0.13 (0.02) *** 0.22 (0.05) 0.13 (0.03) ***
EMG-PSGastrocnemius Soleus 0.17 (0.07) 0.12 (0.03) ** 0.20 (0.06) 0.14 (0.03) *** 0.08 (0.01) 0.04 (0.01) *
Ker-EGI, Ker-electromyography gait index; EMG-PS, electromyography profile score.
Since no significant differences were found between the muscle activations of each limb in either group, the results were pooled across sides for clarity and
are presented for each muscle group (means and standard deviations).
a p values were calculated using the MannWhitney test (* p<0.05; ** p<0.01, *** p<0.001).
doi:10.1371/journal.pone.0161938.t003
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Fig 2. DMDgroup EMGprofiles superimposed on control group EMGprofiles.The percentage of the
gait cycle is presentedon the X-axis (0: heel strike, 100: the following ipsilateral heel strike) and the
normalized amplitude of EMG activity on the Y-axis (0–1). The black (control group) and grey (DMDgroup)
lines represent themean linear envelope of muscle activation (mean of both sides). Dashed lines represent
themean ± standard deviation.
doi:10.1371/journal.pone.0161938.g002
Muscle Activation duringGait and DMD
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Discussion
Altered muscle activity in children with DMD has already been reported in some studies
[5,7,11] however, to our knowledge, no studies had previously quantified pathologicalmuscle
activity or coactivation, either globally or in individual muscles. This study used a recently
developed process of EMG signal analysis to characterise patterns of muscle activity during
gait in children with DMD with gait anomalies, and compared the patterns with those of typi-
cally developing children matched for age and gender. Activity (percentage activation ampli-
tude) of the RF, HS and TA was increased and GAS activity was prolonged in stance compared
with the control children. Activity of the TA was the most pathological, with increased activity
throughout the gait cycle. Greater agonist/antagonist coactivation was found in the children
with DMD, in both the proximal and distal muscles. These original results bring new knowl-
edge of the pathophysiology of gait, particularly regarding adaptive muscle strategies used by
children with DMD to compensate for muscle weakness during gait.
Muscle hyper-activation
The results of this study confirmed quantitatively that the principal muscles of both lower
limbs are hyper-active during gait in children with DMD [5,11]. The increased activity of TA,
HS and RF is likely compensatory since the motor command is intact in these children. Chil-
dren with DMD have 4 factors to compensate for: 1 –weakness of the muscles of the segment,
as well weakness in the whole lower limb; 2 –imbalance of muscle strength within the segment
[2]; 3- non-physiological joint positions such as equinus foot or excessive anterior pelvic tilt;
and 4- loss of balance resulting from the 3 preceding factors. Furthermore, in the current
study, we found that the amount of compensation (hyper-activity) was positively correlated to
the severity of the functional status and gait pattern. In other words, muscle hyper-activity dur-
ing gait increasedwith the progression of the disease. Particularly, the increase in percentage
Table 4. Betweengroup comparison of the co activation index (mean and standard deviation).
DMD Control
Muscle Left Right Mean
RF / HS (N = 13 DMD) 0.15 (0.06) ** 0.14 (0.06) ** 0.09 (0.03)
VL / HS (N = 10 DMD) 0.13 (0.04) p = 0.56 0.12 (0.04) p = 0.91 0.12 (0.03)
TA / GAS (N = 13 DMD) 0.13 (0.04) ** 0.14 (0.04) ** 0.10 (0.03)
RF, rectus femoris; HA, hamstring; VL, vastus lateralis; TA, tibialis anterior;GAS, gastroctemius soleus.
a p values were calculated using the MannWhitney test (* p<0.05; ** p<0.01, *** p<0.001).
doi:10.1371/journal.pone.0161938.t004
Table 5. Correlationsbetweenmuscle activation, kinematics and functional status in childrenwithDMD.
Global indexes of muscle activity Co activation index
Ker-EGI (N = 13) Global EMG-PS (N = 16) RF/HS (N = 16) VL/HS (N = 13) TA/GAS (N = 16)
Vignos functional scale -0.53 p = 0.06 0.57 * 0.66 ** 0.13 p = 0.66 0.15 p = 0.57
GDI 0.57 * -0.59 * -0.55 * -0.49 p = 0.09 -0.62 *
GPS -0.62 * 0.66 ** 0.54 * 0.45 p = 0.13 0.61 *
Gait speed (m/sec) 0.001 p = 0.97 0.19 p = 0.48 -0.09 p = 0.74 -0.63 * -0.12 p = 0.66
Ker-EGI, Ker-electromyography gait index; EMG-PS, electromyography profile score; GDI, gait deviation index; GPS, gait profile score; Values presented
are the mean of both sides.
a p values were calculated using the Spearman correlation test (* p<0.05; ** p<0.01, *** p<0.001).
doi:10.1371/journal.pone.0161938.t005
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activation relative to the maximum recorded activation during gait could be the result of an
increase in muscle fiber recruitment to compensate for weakness in the recordedmuscle. Thus
muscle weakness would be compensated for by an increase in muscle activity in children with
DMD. This suggests that, to produce the same levels of force, children with DMD need greater
muscle activity. However, the multifactorial nature of hyper-activity makes it difficult to estab-
lish a direct link betweenweakness and muscle hyper-activity.
Function of the proximal muscles
The characteristic kinematic gait pattern of children with DMD has been suggested to be the
result of the greater proximal than distal weakness, as well as the presence of muscle contrac-
tures in the more advanced stages of the disease [26]. The children with DMD in the present
study had symmetrical weakness of the lower limbs that was predominant around the pelvis, as
is classically described [2]. They did not have any muscle contractures (Table 2). It has been
hypothetised that children with DMD bend their trunk backwards to keep the center of gravity
behind the hips to prevent jack-knifing at the waist. It has also been suggested that to compen-
sate for increasing knee extensor (quadriceps) weakness, they stabilize the knee by keeping the
center of gravity in front of it [13]. The EMG activity of the RF and HS, as well as their coacti-
vation, was significantly increased throughout almost all of the gait cycle, including swing. This
demonstrates that the EMG activity of proximal muscles is abnormal in DMD, as has previ-
ously been suggested by Sutherland et Patte [5,11]. Since these muscles are the most affected in
DMD, this confirms the hypothesis that hyper-activity compensates for weakness. However,
the activity and coactivation of the VL was not abnormal. Weakness of the quadriceps group
has been shown to be determining for gait in children with DMD [26]. Our results showed that
abnormal activity in this group was particularly related to the RF, despite the fact that it is not
the largest of the quadricepsmuscles. The RF is the only bi-articularmuscle of this group. It
thus appears to have specific role as a stabiliser, by its capacity to keep the center of gravity
behind the hips as well as in front of the knees. The different activities of these two quadriceps
heads supports the idea that each has its own function. Their different functions could be stud-
ied by analysing the correlations between kinematics, dynamic EMG, and morphological (mus-
cle MRI) and anatomopathological data.
Function of the distal muscles
The activity of the TA in the children with DMD was the most abnormal of all the muscles
studied. Paradoxically, this muscle was only moderately weak (mean 4.23/5) (Table 1), which
does not support a relationship betweenweakness and hyper-activity. Moreover, there was a
decrease in TA activity in the children with DMD at the end of the gait cycle compared with
the control children. This hypo-activity could be anticipatory of foot-strike by the forefoot.
This idea is reinforced by the fact that there was a relative hyper-activity of GAS during the ini-
tial part of the stance phase. This suggests that forefoot contact, which is a characteristic of gait
in children with DMD [7], is an adaptive mechanism rather than a gait anomaly caused by
pathological processes. This “voluntary” toe-gait could be a means to increase stability (body
angle relative to the ground). These results invalidate current treatments which involve reduc-
ing equinus (surgery, splints etc.) in children with DMD.
Coactivation
Agonist-antagonist coactivation was greater proximally (RF/HS) but also occurred distally
(TA/GAS), with a significant correlation between the coactivation indexes of these muscles,
and high Vignos score and pathological kinematic gait pattern (GDI, GPS). To our knowledge,
Muscle Activation duringGait and DMD
PLOSONE | DOI:10.1371/journal.pone.0161938 September 13, 2016 9 / 13
this is the first study to quantify this phenomenon during gait in children with DMD. In
healthy subjects, coactivations/co-contractions serve to stabilise joints, and there is a positive
relationship between gait speed and co-contraction in all the segments of the lower limbs. The
gait speed of the children with DMD in the present study was lower than normal, however they
had higher levels of coactivation than the control children. Coactivation has been particularly
studied in children with cerebral palsy [27,28] and has mostly been related to abnormal efferent
commands, which is not the case in children with DMD. These patients develop an imbalance
of muscle strength at every joint (hip flexors remain stronger than hip extensors; knee flexors
(HS) remain stronger than knee extensors (quadriceps); ankle plantarflexors remain stronger
than ankle dorsiflexors) [26]. Muscle weakness and imbalance at any joint leads to a loss of sta-
bility. Coactivation in children with DMD could be a strategy to increase stability around the
knee and ankle. Coactivation of the kneemuscles likely helps the child to maintain the center
of gravity both behind the hips and in front of the knees. However, the predominance of this
compensatory mechanism in the proximal muscles could have negative consequences, such as
reducing the efficiencyof joint motion and increasing the energy cost of gait [25].
Limitations
The lack of statistical significance for some results (EMG-PS of the right RF and EMG-PS of
the left GAS) is probably related to a lack of power due to the size of the sample of children
with DMD. Thus, we were not able to assess the impact of critical factors that may influence
DMD gait, such as corticotherapy (12 children out of 16) [29]. Of the 20 children with DMD
whose gait was recorded, only 16 were included because the goal was to analyse a homogeneous
group of children and gait patterns. A larger study with a follow-up of the children with DMD
should improve the power of these preliminary results.
The limitations of EMG should be considered when interpreting the data, particularly inter-
ference from adjacent muscles and tissues, termed “cross-talk” [30]. This phenomenon pre-
vented the recording of pelvic muscles which are particularly affected in DMD [26]. Moreover,
in this disease, muscle fibers are replaced by fibrous and fatty tissue, altering the impedance of
muscle tissue [31]. Variations in the structure and composition of the underlying soft tissue
might alter the flow of the electrical current and, consequently, the voltage signals measured at
the skin surface. The use of invasive intramuscular EMG electrodeswas not considered appro-
priate for these children. The limitations of EMG should also be considered when interpreting
the relationship betweenmuscle weakness and activation: the EMG signal is a measure of mus-
cle activation but does not measure the contraction/force produced.
The lower gait speed of the children with DMD (Table 2), principally the result of the mus-
cle weakness, could have affected the results. However, Hof et al. and Schwartz showed a posi-
tive relationship between gait speed and amplitude of muscle activation with no significant
effect on “timing” (percentage of the gait cycle) [32,33]. The muscle activity of the children
with DMD in this study was similar or increased compared with the control children, despite
their lower gait speed, thus reinforcing the theory of increasedmuscle activity in these children,
despite the reduction in gait speed.
Clinical impact
According to Petrof [34], dystrophin has a mechanical function on the membrane of muscle
fibres, protecting the tissues from stress duringmuscle contraction. Hyper-activity of muscle
fibres which lack dystrophin could thus affect the progression of the disease. These results sup-
port the controversial principle of avoiding muscle fatigue in children with DMD.
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Based on the results of the present study, we propose that a reasonable rehabilitation objec-
tive would be to increase stability during gait, despite the muscle weakness. Increased stability
would reduce muscle hyper-activity and thus prevent overworking of dystrophin-deficient
muscles. Improving stability using a light dynamic or hinged orthosis, depending on the child’s
gait pattern, might decrease the muscle hyperactivity. Future studies could evaluate the short-
term effects of simple stabilising carbon ankle-foot orthoses or elastic bands on muscle activity
and gait kinematics as well as on the maintenance of gait-capacity in the medium-term.More-
over, muscle hyperactivity could be used as an objective outcome measure of the impact of
pharmacological treatments on DMDmuscle (corticotherapy as well as other potential drug
therapies).
Also with the aim to increase stability during gait, physiotherapy could work to increase bal-
ance and to concentrically strengthen muscles such as TA. However, in a systematic review in
2013 [35], Gianola et al underlined the lack of evidence of effectiveness on stability and the
potentially deleterious effects on strength, highlighting the need for more studies regarding this
issue.
Conclusion
The results of this study showed hyper-activity of the RF and HS, and particularly of the TA
associated with coactivation in both the proximal and distal segments of the lower limbs.
Hyper-activity was not found in the VL and GAS, showing specific adaptations of the RF, HS
and TA during gait. Hyper-activity and coactivation probably compensate for instability
caused by the muscle weakness, however they may have negative consequences on the muscles
and increase energy cost of gait.
Simple therapeutic solutions such as targeted physiotherapy or ankle-foot orthoses could
improve stability and reduce abnormal muscle activity. However, more evidence is necessary
for the formal recommendation of these interventions.
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